-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Recently, the Hubei Provincial Food and Drug Administration issued an announcement stating that according to relevant regulations, the enterprise decided to cancel the "Drug Business License" of Hubei Yifeng Alkang Pharmacy Chain Co.
, Ltd.
according to the application and after review
.
From the date of cancellation, the enterprise immediately ceases drug business activities
.
Coincidentally, on the same day, the Hubei Provincial Food and Drug Administration also issued an announcement on the cancellation of the chain pharmacy headquarters
.
The announcement pointed out that in accordance with the relevant regulations and the application of the enterprise, it was decided to cancel the "Drug Business License" of Wuhan Yifeng Jianghan Pharmacy Chain Co.
, Ltd.
in accordance with the law
.
From the date of cancellation, the enterprise immediately ceases drug business activities
.
The author sorted out and found that in addition to the above two chains, many chain pharmacies have been cancelled one after another this year
.
For example, on April 14, the Guangdong Provincial Food and Drug Administration announced that according to the "Guangdong Provincial Food and Drug Administration's Regulations on the Administration of the Cancellation of the "Drug Business License", the bureau has cancelled the Guangdong Wanshoutang Pharmaceutical Chain Co.
, Ltd.
according to the law.
The "Drug Distribution License" of 6 pharmaceutical distribution companies
.
Among them, two are chain pharmacies.
On April 12, the Hunan Provincial Food and Drug Administration issued an announcement saying that according to the application of the enterprise and according to relevant regulations, the bureau canceled the "Drug Operation" of Zhuzhou Zhengxiang Pharmacy Retail Chain Co.
, Ltd.
according to the law.
License" (No.
: Xiang BA7330052)
.
According to the announcement, the company will not be allowed to engage in any form of drug business from now on
.
In fact, in addition to the above companies, in the past two years, we have often seen announcements on the cancellation of the "Drug Business License" in various places
.
It is understood that Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi, Yunnan and other places have issued multiple announcements to cancel the "Drug Business License", and a large number of pharmacies have withdrawn from the market
.
After industry analysis, it is believed that there are two main reasons for the delisting of pharmacies, including more and more chain pharmacies, which are the market and policies
.
In fact, China's pharmacy market has become saturated
.
According to data from the State Food and Drug Administration, as of the end of June 2021, there were 598,900 "Drug Business License" holders nationwide
.
Among them, there are 6,619 retail chain headquarters, 329,600 retail chain stores, and 249,400 individual drugstores
.
From the perspective of the overall environment, the domestic pharmacy industry has experienced serious overcapacity, and the supply far exceeds the demand
.
It is expected in the industry that competition will further intensify against the backdrop that offline stores are still increasing
.
In addition, due to the impact of the epidemic, online shopping for medicines has become more and more accepted by people, which has further changed people's consumption habits, and has brought a greater and substantial impact on the passenger flow of brick-and-mortar pharmacies
.
Of course, there are also a series of national rectification policies, which will also be a big impact on major pharmacies
.
In general, the current pharmacy industry has entered the stage of "stock competition", and in order to further expand the head chain, it will become the general trend to acquire other pharmacies
.
In this context, the industry expects that in the future, large chain drugstores will continue to intensify mergers and acquisitions to further increase market share, and the industry market concentration will also accelerate
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
, Ltd.
according to the application and after review
.
From the date of cancellation, the enterprise immediately ceases drug business activities
.
Coincidentally, on the same day, the Hubei Provincial Food and Drug Administration also issued an announcement on the cancellation of the chain pharmacy headquarters
.
The announcement pointed out that in accordance with the relevant regulations and the application of the enterprise, it was decided to cancel the "Drug Business License" of Wuhan Yifeng Jianghan Pharmacy Chain Co.
, Ltd.
in accordance with the law
.
From the date of cancellation, the enterprise immediately ceases drug business activities
.
The author sorted out and found that in addition to the above two chains, many chain pharmacies have been cancelled one after another this year
.
For example, on April 14, the Guangdong Provincial Food and Drug Administration announced that according to the "Guangdong Provincial Food and Drug Administration's Regulations on the Administration of the Cancellation of the "Drug Business License", the bureau has cancelled the Guangdong Wanshoutang Pharmaceutical Chain Co.
, Ltd.
according to the law.
The "Drug Distribution License" of 6 pharmaceutical distribution companies
.
Among them, two are chain pharmacies.
On April 12, the Hunan Provincial Food and Drug Administration issued an announcement saying that according to the application of the enterprise and according to relevant regulations, the bureau canceled the "Drug Operation" of Zhuzhou Zhengxiang Pharmacy Retail Chain Co.
, Ltd.
according to the law.
License" (No.
: Xiang BA7330052)
.
According to the announcement, the company will not be allowed to engage in any form of drug business from now on
.
In fact, in addition to the above companies, in the past two years, we have often seen announcements on the cancellation of the "Drug Business License" in various places
.
It is understood that Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi, Yunnan and other places have issued multiple announcements to cancel the "Drug Business License", and a large number of pharmacies have withdrawn from the market
.
After industry analysis, it is believed that there are two main reasons for the delisting of pharmacies, including more and more chain pharmacies, which are the market and policies
.
In fact, China's pharmacy market has become saturated
.
According to data from the State Food and Drug Administration, as of the end of June 2021, there were 598,900 "Drug Business License" holders nationwide
.
Among them, there are 6,619 retail chain headquarters, 329,600 retail chain stores, and 249,400 individual drugstores
.
From the perspective of the overall environment, the domestic pharmacy industry has experienced serious overcapacity, and the supply far exceeds the demand
.
It is expected in the industry that competition will further intensify against the backdrop that offline stores are still increasing
.
In addition, due to the impact of the epidemic, online shopping for medicines has become more and more accepted by people, which has further changed people's consumption habits, and has brought a greater and substantial impact on the passenger flow of brick-and-mortar pharmacies
.
Of course, there are also a series of national rectification policies, which will also be a big impact on major pharmacies
.
In general, the current pharmacy industry has entered the stage of "stock competition", and in order to further expand the head chain, it will become the general trend to acquire other pharmacies
.
In this context, the industry expects that in the future, large chain drugstores will continue to intensify mergers and acquisitions to further increase market share, and the industry market concentration will also accelerate
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
